Molecular markers and allo-HSCT for AML: the latest developments

被引：0
|
作者：
Esteve, J.
Labopin, M.
Brunet, S.
Pigneux, A.
Brands-Nijenhuis, M.
Schouten, H.
Polge, E.
Gorin, N. -C.
Mohty, M.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [1] MOLECULAR MARKERS AND ALLO-HSCT FOR AML: AN UPDATE
    Schmid, C.
    Esteve, J.
    Labopin, M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S90 - S90
  • [2] Sorafenib prevents AML relapse after allo-HSCT
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (10) : 591 - 591
  • [3] T cell transfer after allo-HSCT in AML
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) : 528 - 528
  • [4] T cell transfer after allo-HSCT in AML
    Diana Romero
    Nature Reviews Clinical Oncology, 2019, 16 : 528 - 528
  • [5] Sorafenib prevents AML relapse after allo-HSCT
    Diana Romero
    Nature Reviews Clinical Oncology, 2020, 17 : 591 - 591
  • [6] Extramedullary relapse of the AML following allo-HSCT: a case report
    Ciftciler, R.
    Aladag, E.
    Okay, M.
    Goker, H.
    LEUKEMIA RESEARCH, 2018, 73 : S42 - S42
  • [7] Primum non nocere: allo-HSCT for AML in CR1
    Shouval, Roni
    Soiffer, Robert J.
    BLOOD, 2021, 137 (04) : 438 - 439
  • [8] IMPACT OF ALLO-HSCT IN ADHERENCE
    Kolgaeva, Elmira
    Drokov, Mikhail
    Vybornykh, Dmitri
    Kuzmina, Larisa
    Parovichnikova, Elena
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 663 - 663
  • [9] Microbes matter in pediatric allo-HSCT
    Smith, Melody
    Markey, Kate A.
    BLOOD, 2023, 142 (16) : 1335 - 1337
  • [10] Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT
    Zhang, Tongtong
    Bao, Xiebing
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Fu, Chengcheng
    Sun, Aining
    Ruan, Changgeng
    Wu, Depei
    Chen, Suning
    Xu, Yang
    FRONTIERS IN ONCOLOGY, 2021, 11
12345